跳至主要内容
临床试验/NCT07081061
NCT07081061已完成不适用

A Feasibility Randomized Controlled Trial Evaluating the Effectiveness of a Digital Mental Health Intervention for Moderate/Severe Depression and Anxiety

Teladoc Health0 个研究点目标入组 86 人开始时间: 2025年10月6日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
86
主要终点
Recruitment

研究概览

简要总结

A digital mental health intervention (BetterHelp, Mountain View, CA) provides users with access to online therapy care for treatment of depression and anxiety. This feasibility randomized controlled trial compares clinical outcomes of an intervention group, who will enroll in the digital mental health platform, to a control group.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Has moderate or severe baseline anxiety or depression, as defined by GAD-7 ≥ 10 or PHQ-9 ≥ 10, respectively
  • Based in the US
  • Fluent in the English language
  • Has an email account to receive and complete online surveys
  • Has access to a smartphone, tablet or computer
  • Able to understand and provide informed consent

排除标准

  • Pregnant or plan on becoming pregnant in the next 6 months
  • Has no or mild baseline anxiety or depression, as defined by GAD-7 < 10 and PHQ-9 < 10, respectively

研究组 & 干预措施

Intervention

Experimental

Participants enrolled in a digital mental health platform, which provided access to licensed therapists, group therapy sessions, and a library of educational articles.

干预措施: BetterHelp (Other)

Control

No Intervention

Participants were not enrolled in a digital mental health platform, but continued their standard routine or care as needed.

结局指标

主要结局

Recruitment

时间窗: 90 days

Recruitment rates for study participation

Adherence

时间窗: 90 days

Adherence rates to study procedures

次要结局

  • GAD-7(Baseline, 45 days, 90 days)
  • PHQ-9(Baseline, 45 days, 90 days)

研究者

申办方类型
Industry
责任方
Sponsor

相似试验